Orbital Therapeutics
Leadership & Board
Key Executives
Chief Financial OfficerTerry-Ann Burrell
Co-Founder and ChairmanPeter Barrett
Chief Operating OfficerGillian Ivers-Read
President and Chief Scientific OfficerGiuseppe Ciaramella
Co-FounderNathaniel Brooks Horwitz
Current Number of Employees30
Current LinkedIn Followers18,041
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$270M
Total Amount Raised$270M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$270M
Latest Funding Amount$270M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Orbital Therapeutics had 30 employees as of April 6, 2026. The number of employees decreased by 3 (9.09%) week-over-week.
30Latest Employee Count
3(-9.09%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Orbital Therapeutics had 18,041 followers as of April 6, 2026. The number of followers increased by 17 (0.09%) week-over-week.
18,041Latest Followers Count
17(0.09%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Oct 10, 2025
Series A
$270.00M
―
